Thomas Robert

2.0k total citations
59 papers, 1.1k citations indexed

About

Thomas Robert is a scholar working on Nephrology, Pulmonary and Respiratory Medicine and Molecular Biology. According to data from OpenAlex, Thomas Robert has authored 59 papers receiving a total of 1.1k indexed citations (citations by other indexed papers that have themselves been cited), including 20 papers in Nephrology, 14 papers in Pulmonary and Respiratory Medicine and 12 papers in Molecular Biology. Recurrent topics in Thomas Robert's work include Renal Diseases and Glomerulopathies (14 papers), COVID-19 Clinical Research Studies (6 papers) and Chronic Kidney Disease and Diabetes (6 papers). Thomas Robert is often cited by papers focused on Renal Diseases and Glomerulopathies (14 papers), COVID-19 Clinical Research Studies (6 papers) and Chronic Kidney Disease and Diabetes (6 papers). Thomas Robert collaborates with scholars based in France, United States and Netherlands. Thomas Robert's co-authors include Renato C. Monteiro, Laureline Berthelot, Philippe Dessen, Alexandra Cambier, Vladimir Lazar, Stefan Michiels, Alexander M.M. Eggermont, Véronique Winnepenninckx, Gilbert Lenoir and Joost J. van den Oord and has published in prestigious journals such as JNCI Journal of the National Cancer Institute, Radiology and Clinical Cancer Research.

In The Last Decade

Thomas Robert

51 papers receiving 1.1k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Thomas Robert France 15 478 345 243 204 140 59 1.1k
Koki Mise Japan 20 301 0.6× 567 1.6× 100 0.4× 94 0.5× 212 1.5× 83 1.2k
Eiko Hasegawa Japan 22 299 0.6× 581 1.7× 134 0.6× 111 0.5× 316 2.3× 163 1.4k
Joseph Weisstuch United States 7 344 0.7× 577 1.7× 188 0.8× 313 1.5× 319 2.3× 8 1.3k
Zheng Tang China 16 178 0.4× 264 0.8× 125 0.5× 121 0.6× 239 1.7× 51 796
Mark A. Lusco United States 15 222 0.5× 501 1.5× 71 0.3× 98 0.5× 155 1.1× 90 934
Peter Topham United Kingdom 18 389 0.8× 682 2.0× 227 0.9× 415 2.0× 125 0.9× 29 1.4k
Zhaoyue Wang China 19 218 0.5× 82 0.2× 174 0.7× 190 0.9× 100 0.7× 91 1.2k
Massimo Iacobelli United States 19 347 0.7× 176 0.5× 272 1.1× 422 2.1× 102 0.7× 54 1.9k
Amélie Dendooven Belgium 16 351 0.7× 204 0.6× 98 0.4× 45 0.2× 151 1.1× 61 873
Tien‐Tsai Cheng Taiwan 20 237 0.5× 174 0.5× 188 0.8× 293 1.4× 56 0.4× 78 1.5k

Countries citing papers authored by Thomas Robert

Since Specialization
Citations

This map shows the geographic impact of Thomas Robert's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Thomas Robert with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Thomas Robert more than expected).

Fields of papers citing papers by Thomas Robert

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Thomas Robert. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Thomas Robert. The network helps show where Thomas Robert may publish in the future.

Co-authorship network of co-authors of Thomas Robert

This figure shows the co-authorship network connecting the top 25 collaborators of Thomas Robert. A scholar is included among the top collaborators of Thomas Robert based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Thomas Robert. Thomas Robert is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Pottier, Nicolas, et al.. (2025). Exon location of glycine substitutions impacts kidney survival in autosomal dominant Alport syndrome. Nephrology Dialysis Transplantation. 40(8). 1522–1530.
2.
Robert, Thomas, et al.. (2025). CKDx: a necessary step—but can we go further?. Nephrology Dialysis Transplantation. 40(12). 2217–2221.
3.
Robert, Thomas, et al.. (2025). Kidney Cysts in Alport Syndrome: Illustrative Cases, but Misleading Conclusions. American Journal of Kidney Diseases. 87(1). 134–135.
4.
Sallée, Marion, Noémie Resseguier, Thomas Crépin, et al.. (2024). Immunoadsorption and Plasma Exchange are Comparable in Anti-Neutrophil Cytoplasmic Antibodies or Anti-Glomerular Basement Membrane Removal Kinetics. Kidney International Reports. 9(9). 2767–2773. 2 indexed citations
5.
Robert, Thomas, et al.. (2024). How hyperkalemia affects the heart: clinical implications. Nephrology Dialysis Transplantation. 40(6). 1063–1065.
6.
Lombardi, Yannis, et al.. (2024). Challenging the narrative of Alport syndrome spectrum: no link with cystic phenotype. Nephrology Dialysis Transplantation. 40(7). 1408–1415. 2 indexed citations
7.
Robert, Thomas, et al.. (2024). Systematic Screening of Autosomal Dominant Tubulointerstitial Kidney Disease–MUC1 27dupC Pathogenic Variant through Exome Sequencing. Journal of the American Society of Nephrology. 36(2). 256–263. 3 indexed citations
8.
Raymond, Laure, et al.. (2023). Role of the I416L Variant of Complement Factor I in Thrombotic Microangiopathy Among Patients of African Ancestry. Kidney International Reports. 8(10). 2136–2140. 1 indexed citations
9.
Robert, Thomas, Laure Raymond, Noémie Jourde‐Chiche, et al.. (2023). Diagnosis of Kidney Diseases of Unknown Etiology Through Biopsy-Genetic Analysis. Kidney International Reports. 8(10). 2077–2087. 7 indexed citations
10.
Farnault, Laure, Thomas Robert, Sylvain Choquet, et al.. (2022). Successful treatment with adapted high dose methotrexate in a hemodialysis patient with primary central nervous system lymphoma: 100 mg/m2 seems sufficient. Nefrología (English Edition). 42(2). 130–134. 1 indexed citations
11.
Guervilly, Christophe, Stéphane Burtey, Florence Sabatier, et al.. (2021). Dissemination of extreme levels of extracellular vesicles: tissue factor activity in patients with severe COVID-19. Blood Advances. 5(3). 628–634. 109 indexed citations
12.
Fourié, Toscane, Guillaume Lano, Paola Mariela Saba Villarroel, et al.. (2021). Spike and neutralizing antibodies response to COVID-19 vaccination in haemodialysis patients. Clinical Kidney Journal. 14(10). 2239–2245. 9 indexed citations
13.
Cambier, Alexandra, Marion Rabant, Khalil El Karoui, et al.. (2020). Clinical and histological differences between adults and children in new onset IgA nephropathy. Pediatric Nephrology. 35(10). 1897–1905. 22 indexed citations
14.
Silva, Stein, Bernard Georges, C. Cartery, et al.. (2020). Short- and long-term renal outcomes following severe rhabdomyolysis: a French multicenter retrospective study of 387 patients. Annals of Intensive Care. 10(1). 27–27. 71 indexed citations
15.
Cambier, Alexandra, et al.. (2019). Steroid therapy in children with IgA nephropathy. Pediatric Nephrology. 35(3). 359–366. 18 indexed citations
16.
Cambier, Alexandra, Marion Rabant, Michel Peuchmaur, et al.. (2018). Immunosuppressive Treatment in Children With IgA Nephropathy and the Clinical Value of Podocytopathic Features. Kidney International Reports. 3(4). 916–925. 36 indexed citations
17.
Leibler, Claire, Marie Matignon, Anissa Moktefi, et al.. (2018). Belatacept in renal transplant recipient with mild immunologic risk factor: A pilot prospective study (BELACOR). American Journal of Transplantation. 19(3). 894–906. 30 indexed citations
18.
Robert, Thomas, Anissa Moktefi, Helge Wiig, et al.. (2013). Acute kidney failure with renal carcinomatous lymphangitis secondary to advanced colon cancer. Kidney International. 84(2). 420–420. 1 indexed citations
19.
Robert, Thomas, et al.. (2012). Call-Fleming syndrome associated with convexity subarachnoid hemorrhage. Clinical Neurology and Neurosurgery. 115(6). 796–798. 1 indexed citations
20.
Broutin, Sophie, Nabahet Ameur, Ludovic Lacroix, et al.. (2011). Identification of Soluble Candidate Biomarkers of Therapeutic Response to Sunitinib in Medullary Thyroid Carcinoma in Preclinical Models. Clinical Cancer Research. 17(7). 2044–2054. 30 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Koki Mise Breakdown of academic impact, for papers by Eiko Hasegawa Breakdown of academic impact, for papers by Joseph Weisstuch Breakdown of academic impact, for papers by Zheng Tang Breakdown of academic impact, for papers by Mark A. Lusco Breakdown of academic impact, for papers by Peter Topham Breakdown of academic impact, for papers by Zhaoyue Wang Breakdown of academic impact, for papers by Massimo Iacobelli Breakdown of academic impact, for papers by Amélie Dendooven Breakdown of academic impact, for papers by Tien‐Tsai Cheng
Rankless by CCL
2026